Tech Company Financing Transactions
ViewRay Funding Round
ViewRay closed a $50 million venture capital round on 7/1/2015. Investors included CRG.
Transaction Overview
Company Name
Announced On
7/1/2015
Transaction Type
Debt
Amount
$50,000,000
Round
Undisclosed
Investors
CRG (Charles Tate)
Proceeds Purpose
This debt is part of ViewRay's comprehensive financing strategy to optimize its capital structure and to provide the funding for driving its global expansion. Through the transaction with CRG, ViewRay will initially access $30 million of debt, which is interest only for three years, enabling the company to accelerate the worldwide commercialization of the MRIdian system and to retire $13 million of debt with less favorable terms. The company has the option to draw a further $20 million at its discretion upon achieving certain milestones.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
2 Thermo Fisher Way
Oakwood Village, OH 44146
USA
Oakwood Village, OH 44146
USA
Phone
Website
Email Address
Overview
ViewRay (OTC: VRAY) sells a patent pending Renaissance race System 1000 that combines two proven technologies: magnetic resonance imaging (MRI) and gamma ray radiotherapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Drake
Chief Financial Officer
Ajay Bansal
Chief Medical Officer
Martin Fuss
Chief Operating Officer
Shar Matin
Chief Scientific Officer
James Dempsey
VP - General Counsel
Robert McCormack
VP - Human Resources
Robert Fuchs
Browse more venture capital transactions:
Prev: 7/1/2015: MoBeam venture capital transaction
Next: 7/1/2015: Prevedere venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs